Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden and endotoxin risks.

Overview: Aldeyra Therapeutics, Inc. is a biotechnology company focused on discovering and developing therapies for immune-mediated and metabolic diseases, with a market cap of $260.55 million ...

Viking Therapeutics jumped by 9.74 percent on Tuesday to close at $30.19 apiece as investors repositioned portfolios ahead of the expected release of the results of its own weight loss drug ...

By Kelly Cloonan Century Therapeutics plans to cut 51% of its employees as it looks to focus on programs with the highest potential for value.

Plus Therapeutics plans to present additional data from the completed single-dose trial at the upcoming SNO/ASCO CNS Metastases Conference in August and will request an End of Phase 1 meeting with ...

Investing.com -- MiNK Therapeutics, Inc. (NASDAQ: INKT) stock soared 200% after the company announced a complete remission in a patient with metastatic testicular cancer following treatment with ...

About This Event Axsome Therapeutics (Nasdaq: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, visits the Nasdaq MarketSite in Times ...

Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — achieving the efficacy goals of a clinical trial.

MiNK Therapeutics shares jumped as new clinical data show durable remission in testicular cancer and tumor reduction in gastric cancer using its iNKT cell therapy, agenT-797, in combination with ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment analysis of VKTX stock.

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an unrelated drug.

Sarepta recently announced it would lay off 500 workers, including 80 in central Ohio.